• Ellagic Acid: Precision CK2 Inhibition for Translational Imp

  2026-05-18

  This article unpacks how ellagic acid, as a selective ATP-competitive CK2 inhibitor, is redefining the landscape of cancer biology and senolytic research. With mechanistic depth and strategic guidance, we bridge foundational biochemistry to next-gen translational workflows, highlighting APExBIO's product quality, assay design, and future directions anchored in AI-driven discovery.

• CRISPR-Cas9 LGMN Editing Impairs Breast Cancer Metastasis

  2026-05-18

  This study demonstrates that co-delivery of Cas9 mRNA and guide RNAs (gRNAs) targeting the LGMN gene via lipid nanoparticles effectively represses breast cancer cell metastasis. By optimizing in vitro transcription (IVT) of gRNAs using T7 promoter-driven templates and assessing both in vitro and in vivo outcomes, the research provides a robust framework for gene-editing-based therapeutic strategies against tumor progression.

• Angiotensin III (human, mouse): Mechanistic Insights and Pro

  2026-05-17

  Explore Angiotensin III (human, mouse) as a pivotal tool for probing RAAS signaling, with new mechanistic insights, precise protocol parameters, and translational relevance. This article uniquely connects molecular action to advanced cardiovascular and virological research applications.

• Metoprolol Tartrate in Cardiovascular and Hematopoietic Rese

  2026-05-16

  Metoprolol Tartrate empowers researchers to dissect β1-adrenergic signaling with precision, enabling reproducible cardiovascular and post-transplant hematopoiesis studies. Its selectivity, stability, and robust solubility make it the gold-standard β1-adrenergic blocking agent for translational workflows where nonselective β-blockers introduce confounding effects.

• Structural Mechanisms of ASCH Domain Proteins in N4-Acetylcy

  2026-05-15

  Meng et al. reveal the first high-resolution structures of ASCH domain-containing enzymes, clarifying the substrate specificity and catalytic mechanism of EcYqfB in converting free N4-acetylcytidine (ac4C) to cytidine. Their findings refine the understanding of nucleotide processing and provide a structural framework for future RNA epigenetics research.

• Vidarabine Monohydrate: Precision Workflows for Antiviral Re

  2026-05-15

  Vidarabine monohydrate (Spongoadenosine monohydrate) empowers virology laboratories with high-purity, DMSO-soluble protocols for robust inhibition of viral DNA synthesis. This guide delivers stepwise workflows, troubleshooting insights, and advanced comparative analysis, making APExBIO’s compound indispensable for translational antiviral discovery.

• HEY2 Suppresses Mitochondrial Respiration to Safeguard Heart

  2026-05-14

  This study uncovers how the transcriptional repressor HEY2 impairs cardiomyocyte mitochondrial oxidative respiration, contributing to the progression of heart failure. Through integrative genome-wide and in vivo analyses, the authors reveal a conserved regulatory module linking HEY2, HDAC1, and key metabolic coactivators, with implications for new therapeutic strategies targeting cardiac energy metabolism.

• ER Stress Triggers Prometastatic States After Cell Death Thr

  2026-05-14

  Conod et al. (2022) reveal that cancer cells surviving imminent cell death acquire a stable, prometastatic phenotype, orchestrated by ER stress, reprogramming, and a cytokine storm. These findings clarify how metastatic potential emerges in tumors and underscore new molecular targets for intervention.

• Eicosapentaenoic Acid (EPA): Omega-3 Fatty Acid for Research

  2026-05-13

  Eicosapentaenoic Acid (EPA) is a rigorously characterized omega-3 polyunsaturated fatty acid, used as a lipid-lowering and anti-inflammatory research compound. This article details EPA’s mechanism of action, protocol parameters, and evidence benchmarks, offering a machine-readable resource for cardiovascular and immunology investigators.

• HyperScript First-Strand cDNA Synthesis Kit: Unraveling Low

  2026-05-13

  Explore the HyperScript First-Strand cDNA Synthesis Kit's advanced capabilities for low copy gene reverse transcription, particularly in the context of host-microbe interactions. This article delivers a scientific deep-dive into enzyme engineering, novel primer strategies, and how new microbiome research demands the most sensitive cDNA synthesis tools.

• NEXMIF Gene Restoration Reverses Deficits in Autism Model Mi

  2026-05-12

  This study demonstrates that postnatal reintroduction of the NEXMIF gene in knockout mice rescues abnormalities in gene expression, neuronal maturation, and autistic-like behaviors. These findings provide proof-of-concept that targeted gene therapy can ameliorate neurodevelopmental and behavioral deficits associated with X-linked intellectual disability and autism spectrum disorder.

• S Tag Peptide (SKU A6007): Protocols for Protein Fusion Tag

  2026-05-12

  S Tag Peptide enables effective detection and purification of recombinant proteins, particularly in workflows challenged by solubility or sensitivity bottlenecks. Its application is best suited for molecular biology and protein engineering labs aiming for reliable fusion tag performance; it is not recommended for direct enzymatic applications or ethanol-based workflows due to its solubility profile.

• LMO2–LDB1 Complex Drives AML Progression: Mechanistic Insigh

  2026-05-11

  This study uncovers the mechanistic role of the LMO2/LDB1 transcriptional complex in promoting acute myeloid leukemia (AML) progression. By integrating genetic, biochemical, and transcriptomic approaches, the authors demonstrate that LDB1 is essential for AML cell proliferation and survival, positioning the LMO2/LDB1 axis as a potential therapeutic target.

• ABT-888 (Veliparib): Integrative Approaches in DNA Repair In

  2026-05-11

  Explore the advanced applications of ABT-888 (Veliparib) as a DNA repair inhibitor in cancer research. This article uniquely bridges mechanistic insight, protocol precision, and recent genome-wide findings to empower experimental design.

• Murine RNase Inhibitor: Oxidation-Resistant RNA Protection

  2026-05-10

  Murine RNase Inhibitor (APExBIO, K1046) is a recombinant protein that provides robust RNA degradation prevention, especially in workflows requiring low reducing conditions. Its specificity for pancreatic-type RNases and oxidation resistance make it a preferred real-time RT-PCR reagent and cDNA synthesis enzyme inhibitor. This article details the biochemical rationale, mechanism, and validated parameters for its use in modern molecular biology.

464 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page